Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mapi Pharma Ltd.

Value-added oral and depot dosage drugs

This article was originally published in Start Up

Executive Summary

Mapi Pharma Ltd. intends to create added-value and patentable products based on combining off-patent drugs with its innovative oral and depot delivery systems, both for its in-house pipeline and for its clients. The Israeli start-up also manufactures complex, bulk, active pharmaceutical ingredients, generic and innovative intermediates, and finished dosage forms.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC092499

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel